Corcept Therapeutics | CORT - Stock


Corcept Therapeutics reported $12.87M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Assertio Holdings USD 24.76M 8.12M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Corcept Therapeutics USD 12.87M 519K Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
J&J USD 14.19B 45M Dec/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
Merck USD 6.44B 157M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 157.68M 9.52M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025